Organon and Sempre Health announce collaboration on new service to help eligible patients save money and stay on their medication as prescribed

Organon (NYSE:OGN) and Sempre Health today announced a strategic partnership designed to motivate eligible patients to refill their prescriptions on time and improve adherence through an innovative pricing program that offers personalized support.

FDA labels recall of discontinued Olympus endoscope accessory as Class I

Listen to the article 4 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: The Food and Drug Administration

February 4, 2025

Revive Therapeutics Announces Results of Phase 3 Clinical Study for Bucillamine in the Treatment of COVID-19 – Psychedelic Alpha

TORONTO, July 06, 2023 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused

July 10, 2023

New prognostic marker identified for gastric cancer recurrence risk

Surgical removal of the tumor is considered the basis for curing gastric cancer. However, 40 per cent of patients who have undergone surgery suffer a

July 30, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.